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Materials and Methods 
Bacterial strains, media, and plasmids 
Bacteroides fragilis NCTC9343 was grown in Brain Heart Infusion (BD) supplemented with 5 
µg/ml hemin (Frontier Scientific) and 5 µg/ml vitamin K1 (Sigma) in an anaerobic atmosphere 
of 80% nitrogen, 10% carbon dioxide, and 10% hydrogen. For selection, 200 µg/ml gentamicin, 
10 µg/ml erythromycin, 10 µg/ml chloramphenicol, or 2 µg/ml tetracycline was added. For in 
vivo studies, B. fragilis carried a marker plasmid pFD340-Chlor or pFD340-Tet which confer 
resistance to chloramphenicol and tetracycline, respectively, allowing identification of multiple 
strains within an animal without affecting their fitness (26). PSC was deleted by allelic exchange 
with a suicide plasmid (pNJR6) as previously described (26). Details for all strains and plasmids 
are listed in Table S4 and primers for cloning in Table S5. 
 
Mice 
All mouse experiments were performed in accordance with the NIH Guide for the Care and Use 
of Laboratory Animals using protocols approved by the Institutional Animal Care and Use 
Committee at the California Institute of Technology. Swiss Webster, C57BL/6, Rag1-/-, and 
BALB/c mice from Taconic Farms and BALB/c IgA-/- mice from the Baylor College of 
Medicine were C-section rederived germ-free and bred in flexible film isolators. Unless 
specifically stated, Swiss Webster mice were used for all experiments due to ease of breeding in 
gnotobiotic conditions. Eight-week-old germ-free mice were transferred to autoclaved 
microisolator cages supplied with autoclaved chow (LabDiet 5010) and autoclaved water 
containing 10µg/ml erythromycin (to select for marker plasmids) and 100µg/ml gentamicin (to 
which Bacteroides are naturally resistant). Mice were mono-colonized by a single oral gavage of 
10^8 CFU in 100µl of HBSS with 1.5% sodium bicarbonate and maintained for at least 4 weeks 
prior to any imaging, mucosal plating, gene expression, or colonization experiments. 
Colonization was confirmed for all mice and monitored over time using freshly collected fecal 
samples. Feces were weighed, mashed and vortexed in 1 ml BHI, spun at 400 g for 1 minute to 
pellet debris, and then diluted for CFU plating. 
 
For depletion of B cells, 8-week-old germ-free Swiss Webster mice were injected 
intraperitoneally with 250 µg of monoclonal anti-mouse CD20 antibody (clone 5D2 from 
Genentech) or 250 µg of an isotype control (IgG2a from Bio X Cell). One week later, mice were 
mono-colonized. One week after that, the mice were given a second identical antibody injection. 
Four weeks after mono-colonization, the mice were used for horizontal transmission 
experiments. 
 
Horizontal transmission and sequential gavage colonization assays 
For horizontal transmission experiments, pairs of mono-colonized female mice were cohoused in 
a new autoclaved cage for 4 hours during the day (16 hours overnight for BALB/c mice, which 
exhibited a higher threshold for invasion), then individually housed in new autoclaved cages. For 
each experiment, the antibiotic resistance markers (Tet and Chlor) were swapped for half the 
animals (for example: WT-Tet vs. ∆ccf-Chlor, and then WT-Chlor vs. ∆ccf-Tet) to ensure that 
the difference in horizontal transmission was due to the bacterial or mouse genotype and not due 
to the different antibiotic resistance markers. The same assay was performed in specific pathogen 
free (SPF) BALBc mice by first treating with ciprofloxacin and metronidazole as described 
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previously (26) to allow colonization with B. fragilis. For sequential gavage experiments, mice 
mono-colonized for three weeks were gavaged with 108 CFU of the challenge strain in HBSS 
with 1.5% sodium bicarbonate and subsequently single-housed. The community-level 
comparison of BALB/c mice (Fig. 4H and I) was made by gavaging 8-10 week-old mice with 
100 µl cecal contents (donors: 8 week-old Swiss Webster mice delivered from Taconic, 2 male 
and 2 female cecums dissected and pooled) homogenized to saturation in HBSS with 1.5% 
sodium bicarbonate. Mucus and lumen samples were collected 5 weeks after colonization. 
 
Sample preparation for electron microscopy 
A 1 cm portion of ascending colon from mono-colonized mice was excised and immediately 
fixed with an ice-cold solution of 3% glutaraldehyde, 1% paraformaldehyde, 5% sucrose in 0.1 
M sodium cacodylate trihydrate, without flushing of the intestinal contents.  Tissues were 
prefixed for 1 hour at 4°C, then transferred to a petri dish containing 5% sucrose in 0.1 M 
cacodylate buffer.  Tissues were cut into ~1-2 mm3 blocks with a #11 scalpel and placed into 
brass planchettes (Type A; Ted Pella, Inc., Redding, CA), prefilled with cacodylate buffer 
containing 10% Ficoll (70 kD, Sigma-Aldrich) which serves as an extracellular cryoprotectant.  
Excess buffer was removed with Whatman filter paper and the sample covered with a Type B 
brass planchette.  Samples were ultra-rapidly frozen with a HPM-010 high-pressure freezing 
machine (Leica Microsystems, Vienna Austria), then transferred immediately under liquid 
nitrogen to cryotubes (Nunc) containing a frozen solution of 2.5% osmium tetroxide, 0.05% 
uranyl acetate in acetone.  The tubes were loaded into a AFS-2 freeze-substitution machine 
(Leica Microsystems) precooled to -100°C.  Samples were processed at -90°C for 72 hours, 
warmed over 12 hours to -20°C, held at that temperature for 6-10 hours, then warmed to 4°C for 
1 hour.  The fixative was removed and the samples rinsed 4 x with cold acetone, infiltrated into 
Epon-Araldite resin (Electron Microscopy Sciences, Port Washington PA) and flat-embedded 
between two Teflon-coated glass slides.  Resin was polymerized at 60°C for 48 hours. 
 
Electron microscopy and dual-axis tomography 
Flat-embedded colon samples were observed with a stereo dissecting microscope to ascertain 
preservation quality and select appropriate regions for EM study.  These were extracted with a 
microsurgical scalpel and glued to the tips of plastic sectioning stubs.  Semi-thick (300 or 400 
nm) serial sections were cut with a UC6 ultramicrotome (Leica Microsystems) using a diamond 
knife (Diatome, Ltd. Switzerland).  Sections were placed onto Formvar-coated copper-rhodium 1 
mm slot grids (Electron Microscopy Sciences) and stained with 3% uranyl acetate and lead 
citrate.  Gold beads (10 nm) were placed on both surfaces of the grid to serve as fiducial markers 
for subsequent image alignment. Grids were placed in a dual-axis tomography holder (Model 
2040, E.A. Fischione Instruments, Export PA) and imaged with a Tecnai TF30ST-FEG 
transmission electron microscope (300 KeV; FEI Company/ThermoFisher Scientific, Hillsboro 
OR) equipped with an XP1000 2k x 2k CCD camera (Gatan, Inc. Pleasanton CA). Tomographic 
tilt-series and large-area montaged overviews were acquired automatically using the SerialEM 
software package (49).  For tomography, samples were tilted +/- 64° and images collected at 1° 
intervals. The grid was then rotated 90° and a similar series taken about the orthogonal axis. 
Tomographic data was calculated, analyzed and modeled using the IMOD software package (50, 
51). For quantification of epithelial associated bacteria (Fig. 1F and 4J), sections were surveyed 
until a bacterium on the apical epithelial surface was identified, and then a ~20 x 20 µm 
montaged projection image was acquired. Bacterial cells were identified by morphology and 
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counted. About 1 mm length of epithelium was scanned per mouse, including an area of around 
20 µm from the apical epithelial surface into the mucus. For measurement of the capsule 
thickness (Fig. 1I), the distance between the outer membrane and edge of the electron-dense 
capsule layer was measured in tomograms. Ten different measurement sites on the same cell 
were averaged for each cell. 
 
Mucosal scraping for CFU quantification or sequencing analysis 
The ascending colon was dissected and cut open longitudinally. Lumen content was removed, 
and the flat tissue was washed with HBSS until no feces could be observed. A 1 cm length of the 
tissue was cut, making an approximately 1 cm x 1 cm square of flat tissue. Mucus was removed 
from the epithelial surface by holding one corner of the tissue and using light pressure with a 
sterile plastic 1.8 cm cell scraper (BD Falcon). For sequencing analysis, mucus was frozen at this 
point. For CFU quantification, the mucus was moved into a 2 ml screw cap tube with 1.4 mm 
ceramic beads (Lysing Matrix D, MP Biomedicals) and 1 ml of HBSS and bead beat on medium 
for 1 minute to homogenize the mucus. This homogenate was diluted for CFU plating. 
 
RNA isolation 
Pelleted mid-log bacterial cultures, freshly harvested colon lumen contents, or whole colon tissue 
were immediately lysed by bead-beating in a mixture of 500 µl buffer (0.2 M NaCl and 20 mM 
EDTA), 210 µl 20% SDS, and 500 µl phenol, chloroform, and isoamyl alcohol (Ambion 
AM9720). The aqueous phase was separated by centrifugation and moved to a new tube for a 
second extraction with phenol, chloroform, and isoamyl alcohol. Then, 50 µl of 3 M sodium 
acetate and 500 µl of cold ethanol were mixed in to the aqueous fraction and placed on ice for 20 
minutes. RNA was pelleted and washed once with cold 70% ethanol then resuspended in 100 µl 
water. RNA was further purified using the Qiagen RNeasy mini kit according to the 
manufacturer instructions. DNA was removed using Turbo DNase (Ambion AM2238) for one 
hour at 37 C before applying to a second Qiagen RNeasy column, including an on-column 
Qiagen RNase-free DNase digest. 
 
qRT-PCR 
First-strand cDNA synthesis from total RNA was achieved using the manufacturer’s instructions 
for the iScript cDNA synthesis kit (Bio-Rad). Reactions were run on an ABI PRISM 7900HT 
Fast Real-Time PCR System (Applied Biosystems) with Power SYBR Green PCR Master Mix 
(Applied Biosystems). Relative quantification was performed using the ∆∆Ct method with gyrB 
(DNA gyrase) as the housekeeping control gene. The mean Ct value from 3 technical replicates 
was used for each biological replicate. Primers are listed in Table S5. 
 
RNAseq 
For bacterial RNAseq (Fig. 2A), 10 ml liquid cultures were harvest at mid-log phase and total 
RNA was isolated as described above (RNA isolation). Libraries were prepared using NEBNext 
Ultra RNA Library Prep Kit for Illumina (NEB E7530) according to the manufacturer’s 
instructions and sequenced on an Illumina HiSeq2500 in single read rapid run mode with single-
end 50 bp reads. For each sample, at least 2.5 million reads mapped to protein-coding genes. The 
bacterial RNAseq analysis package Rockhopper (52) was used for quality filtering, mapping, and 
differential expression analysis. 
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For mouse RNAseq (Fig. 3A), a 1 cm length of opened and washed ascending colon tissue was 
prepped for total RNA as described above (RNA isolation). Ribosomal RNA was depleted using 
a Ribo-Zero Magnetic Gold Epidemiology Kit (Epicentre/Illumina). Sequencing was done on an 
Illumina HiSeq2500 to produce 101-bp paired-end reads. Reads were trimmed with a Phred 
quality score cut-off of 20 using fastq_quality_trimmer from the FASTX toolkit, version 0.0.13 
(http://hannonlab.cshl.edu/fastx_toolkit/). Reads shorter than 20 bp after adaptor and poly(A)-
trimming were discarded. Trimmed reads were aligned to the mouse genome (build 
GRCm38.p4) by STAR (53), read counts were quantified using HTseq (54), and differentially 
expressed genes were identified using edgeR (55). 
 
Bacterial flow cytometry 
Fresh fecal pellets were mashed and vortexed in 1 ml of HBSS per 100 mg feces. Large debris 
was removed by centrifugation at 400 x g for 5 minutes. Supernatants, containing fecal bacteria, 
were diluted to 106 CFU per well in 96-well v-bottom plates, washed with HBSS, and stained 
with a monoclonal rat anti-mouse IgA conjugated to PE (eBioscience clone mA-6E1) or 
monoclonal rat anti-mouse IgM conjugated to PE (Biolegend clone RMM-1) at 1:250 and SYTO 
9 nuclear stain (Molecular Probes) at 1:1000. After washing twice with HBSS, stained bacteria 
were analyzed on a MACSQuant VYB (Miltenyi). Data were analyzed using FlowJo. 
 
For IgA affinity studies, IgA was extracted from fresh fecal samples by mashing and vortexing in 
1 ml HBSS per 100 mg feces, then removing the insoluble fraction by centrifuging at 16,000 x g 
for 10 minutes at 4 C, and collecting the supernatant containing soluble IgA. The pellet was 
resuspended in the same volume for a second extraction. The combined supernatant was then 
sterile filtered, heat inactivated at 56 C for 30 minutes, and then stored at 4 C for up to 1 month 
(degradation was not observed by ELISA in this timeframe). IgA concentrations were measured 
using a Ready-SET-Go mouse IgA ELISA kit (eBioscience) according to the manufacturers 
protocol. Binding assays were performed on fecal-derived bacteria from mono-colonized Rag1-/- 
mice so that the bacteria were in vivo-adapted (in which ccf is induced and the thick capsule is 
formed), but IgA-free (because Rag1-/- mice do not make antibody). 106 CFU per well in 96-well 
plates was incubated on a shaker with 200 µl IgA at a concentration of 1 µg / ml for 30 minutes 
and then stained for flow cytometry. 
 
Western blot 
Fresh fecal pellets from Rag1-/- mice were mashed and vortexed in 1 ml of BHI per 100 mg 
feces. Large debris was removed by centrifugation at 400 x g for 5 minutes. This supernatant or 
late-log cultures of bacteria were pelleted at 8,000 g and resuspended at 10X concentration in 
BHI. The concentrate was mixed 1:1 with 2X Laemmli sample buffer and boiled for 10 minutes 
to lyse bacteria. 20 µl of lysate (108 CFU) was loaded per well in tris-glycine gels with a 4-20% 
polyacrylamide gradient (Novex WedgeWell), ran in a tris-glycine buffer with 0.1% SDS (Bio-
Rad). Gels were transferred at 4 C overnight to a PVDF membrane in the same buffer 
supplemented with 20% methanol. PVDF blots were blocked for 1 hour in PBS-T (PBS with 
0.1% Tween20) with 5% powdered milk, washed with PBS-T, and then stained with IgA, 
extracted from feces as described above, at a final concentration of 0.1 µg / ml in PBS-T with 
2.5% powdered milk for 2 hours. Blots were washed four times with PBS-T, stained with an 
HRP goat anti-mouse IgA (Southern Biotech 1040-05) diluted 1:1000 in PBS-T with 2.5% 
 7 
powdered milk for 1 hour, washed four times again, and then developed with a Clarity western 
ECL substrate (Bio-Rad). 
 
Tissue-cultured epithelial cell adherence assay 
Intestinal epithelial cell lines HT29, HT29-MTX, and Caco-2 were maintained in high glucose 
DMEM with 4 mM L-glutamine, 4.5 g / L glucose (HyClone), supplemented with 10% fetal 
bovine serum (FBS) (Gibco), and penicillin-streptomycin solution (Corning). Cells were seeded 
in flat 96-well plates at a density of 25,000 cells per well and then grown for seven days past 
confluence to allow production of mucus. IgA was extracted and bound to fecal-derived bacteria 
from mono-colonized Rag1-/- mice so that the bacteria were in vivo-adapted but IgA-free as 
described above (Bacterial flow cytometry for IgA coating and affinity). IgA-coated bacteria 
were pelleted and resuspended in high-glucose DMEM without antibiotics or FBS. Epithelial 
cells were washed once with HBSS and then incubated with 106 coated bacteria for 2 hours at 37 
C in an anaerobic atmosphere of 80% nitrogen, 10% carbon dioxide, and 10% hydrogen to allow 
adherence of bacteria. Bacterial growth was not observed within this timeframe either on 
epithelial cells or in media alone. Wells were washed twice with 200 µl HBSS to remove 
unbound bacteria, and then trypsinized with 50 µl of 0.05% trypsin in HBSS (Corning) for 20 
minutes at 37 C to disassociate epithelial cells. Then 50 µl of BHI was added and cells were 
vigorously resuspended before dilution plating for CFU. Fraction bound was calculated as the 
output CFU / input CFU. For all epithelial cell adherence assays, the average of 4 technical 
replicates (4 separate binding reactions with the same IgA and bacteria on 4 wells of cells) is 
reported for each biological replicate. 
 
B cell flow cytometry 
Cells were isolated from the peritoneum, mesenteric lymph nodes, and colon tissues. The 
peritoneal space was injected with PBS and massaged for thirty seconds to suspend cells. 
Mesenteric lymph nodes were dissected and single cell suspensions were obtained by grinding 
tissues through a 100 µm cell strainer. Colonic lamina propria lymphocytes were isolated by first 
flushing lumen contents away with PBS, and removing the longitudinal and circular muscle 
layers of the colon by micro-dissection. The remaining tissue was incubated in 1 mg / mL 
Collagenase II (Dibco) for 1 hour and then cells were filtered through a 100 µm cell strainer. 
Cells were spun down, resuspended and separated by a 40%/80% (v/v) Percoll (GE Healthcare) 
density gradient. All cells were washed in complete RPMI buffer, allowed to rest at 37 C for at 
least 1 hour in a 5 % CO2 tissue culture incubator, and incubated in 5% mouse serum for 15 
minutes before proceeding to staining for flow cytometry. Cells were stained with a 
LIVE/DEAD fixable Violet dye (Life Technologies), FITC-conjugated B220 antibody 
(eBioscience clone RA3-6B2), and PerCP-Cy5.5-conjugated CD3e antibody (eBioscience clone 
145-2C11) for 20 minutes at 4 C. Cells were washed in HBSS with 1% BSA and fixed in 2% 
PFA prior to acquisition on a MACSQuant Analyzer (Miltenyi). Data were analyzed using 
FlowJo. 
 
Sorting IgA-bound bacteria for sequencing 
This method was carried out as previously described (35). Two fecal pellets were mashed and 
resuspended in 1 ml PBS with 0.5% BSA (this buffer used throughout the protocol). The 
homogenate was centrifuged at 400 g for 5 minutes to remove debris, and the supernatant was 
passed through a 30 µm filter. Bacteria were pelleted by centrifugation at 8000 g for 5 minutes 
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and resuspended in 1 ml buffer plus 35 µl of anti-IgA PE (eBioscience clone mA-6E1) and 
stained for 20 minutes at 4 C. Stained bacteria were pelleted, washed once, then resuspended in 1 
ml buffer plus 100 µl ultrapure anti-PE magnetic beads (Miltenyi) and incubated for 15 minutes 
at 4 C. Bead-bound, stained bacteria were pelleted and resuspended in 500 µl buffer and then run 
over an MS column (Miltenyi) on an OctoMACS separator (Miltenyi). Bound bacteria were 
eluted and re-loaded on the column three times to further purify. 
 
16S amplicon sequencing 
DNA was extracted from tissue scrapings, fecal samples, and IgA-sorted bacterial pellets using 
the Qiagen PowerMag Soil extraction kit and a ThermoFisher KingFisher magnetic bead 
purification robot. Extracted DNA was amplified and sequenced as in Caporaso et al (56). 
Briefly, the V4 region of the 16S ribosomal RNA gene was amplified in triplicate using the 
515F/805R primers from the Earth Microbiome Project (57) and amplicons pooled and 
sequenced on an Illumina MiSeq instrument. Sequences were uploaded to the Qiita analysis 
platform for demultiplexing and primary data processing (https://qiita.ucsd.edu/). Exact sequence 
variants (ESVs) were identified and chimeric sequences removed using the Deblur plugin in 
Qiita (58). For phylogenetic analyses, ESVs were inserted into the GreenGenes reference 
phylogeny (release 13_8, (59))using SEPP (60). Taxonomy was assigned per ESV according to 
its placement in the GreenGenes phylogeny using the fragment-insertion pluging in Qiime 2 
v2017-12 (https://qiime2.org). Samples yielding less than 1000 Deblurred sequences were 
excluded from subsequent analysis. 
 
16S diversity analyses 
We used the Galaxy implementation LEfSe (61) to identify taxonomic groups that were 
significantly enriched (LDA effect size ≥ 2) in bacterial pellets purified using anti-IgA 
antibodies, coding pellet sort status as a class and mouse sex as subclass and normalizing to 10^6 
counts per sample. To identify specific ESVs differentially represented in tissues or feces of 
BALB/c and BALB/c IgA-/- mice, we used the DESeq2 (62) in R (63), adding a pseudocount of 1 
to all ESVs and fitting models using a negative binomial distribution. Analyses of microbial 
community beta-diversity were performed using the Weighted UniFrac metric (64) calculated 
from count tables rarefied to 1000 sequences in Qiime2. Principle Coordinate Analyses and 
Adonis tests of group differences in central tendency (65) were performed in the Vegan package 
in R (66). 
 
Statistical methods 
All bar graphs show mean values with standard error of measurement. Log-scale line graphs for 
horizontal transmission and sequential gavage assays show the geometric mean and 95% 
confidence interval. Post-hoc corrections for multiple comparisons were the Tukey method when 
comparing all groups with each other and Sidak for other types of comparisons. 
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Fig. S1. Additional EM images from mice mono-colonized with wild-type B. fragilis. (A and 
B) Example aggregates of B. fragilis on the epithelial surface in projection images (left) with 
high resolution tomograms of the marked region (right). Arrows indicate examples of bacteria 
penetrating the glycocalyx. (C) Projection and inset tomogram of an additional example of B. 
fragilis in a crypt of Lieberkühn. 
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Fig. S2. 
Additional in 
vivo phenotypes 
for various B. 
fragilis strains. 
(A) Abundance of 
the initial strains 
corresponding to 
Fig. 2D, (B) Fig. 
2E, (C) Fig. 2F, 
and (D) 2G (n = 
9-12). (E) 
Abundance of 
foreign strains in 
mice originally 
mono-colonized 
with indicated 
strain (n = 6) and 
challenged by 
gavage. (F) 
Abundance of the 
original strains 
corresponding to 
E (geometric 
mean and 95% 
confidence 
interval plotted 
for all line graphs 
with Sidak 
repeated measure 2-way ANOVA on log-transformed data). (G) qRT-PCR analysis for ccf 
expression of RNA extracted from colon lumen contents of mono-colonized mice, indicating that 
PSB/C mutation does not affect ccf expression (Tukey ANOVA, n = 3). (H) Quantification of 
bacteria in the colon lumen of mono-colonized mice, corresponding to Fig. 2I (Tukey ANOVA, 
n = 8). (I) High resolution tomogram (image width = 600 nm) of B. fragilis ∆PSB/C in the colon 
mucosa of a mono-colonized mouse and (J) quantification of the capsule thickness including 
data from Fig. 1I for wild-type and ∆ccf (Tukey ANOVA, n = 10). (K) Example projection 
montage of the apical surface of the epithelium of mice mono-colonized with B. fragilis ∆PSB/C 
shows aggregates of only small numbers of bacteria. (L) Quantification of number of epithelial 
associated bacteria including data from Fig. 1F for wild-type and ∆ccf (Tukey ANOVA, n = 7, 8, 
8 images from 4 mice per group) (* p < 0.05, ** p < 0.01, *** p < 0.001). 
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Fig. S3. Host inflammatory profiles of B. fragilis and B. fragilis ∆ccf show no differences. 
(A) Expression levels of inflammatory cytokines, lysozyme, and antimicrobial peptides from 
ascending colon RNAseq of mice mono-colonized with B. fragilis or B. fragilis ∆ccf reveal an 
indistinguishable inflammatory response (n = 3). Beta-defensins, TNFa, IL-1b, and IL-6 were 
not expressed at detectable levels. 
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Fig. S4. 
Interactions 
between IgA 
and B. fragilis. 
(A) Gating 
strategy for 
assessing IgA 
coating of 
bacteria. Gates 
were defined 
using single-
stained samples. 
(B) Lysates of 
culture-grown 
Bacteroides 
species (108 
CFU loaded per 
well for all 
blots) probed in 
western blots 
with fecal IgA 
from B. fragilis 
mono-colonized 
mice, indicating 
minimal cross-
reactivity to 
other species. 
(C) Lysates of 
B. fragilis strains from the feces of mono-colonized Rag1-/- mice probed in western blots with 
fecal IgA from germ-free and (D) B. thetaiotaomicron mono-colonized mice, with images 
overexposed to show minimal binding (blots B-D repeated at least 3 times). (E) Plating CFU 
before and after coating with IgA in vitro suggests no impact of IgA on the viability of B. fragilis 
(Tukey ANOVA, n = 8). (F) Tissue-cultured epithelial cell adherence assay with various cell 
lines (in addition to those used in the main text), using wild-type B. fragilis from feces of mono-
colonized Rag1-/- mice and IgA from mice mono-colonized with B. fragilis (Sidak 2-way 
ANOVA, n = 5 mice as the source of bacteria) (G) Additional controls for Fig. 3H (first two bars 
are the same data as in Fig. 3H) indicate no baseline difference in epithelial adherence between 
strains of B. fragilis from feces of mono-colonized Rag1-/- mice, without the addition of IgA 
(Tukey ANOVA, n = 4) (* p < 0.05, ** p < 0.01, *** p < 0.001). 
  
bacteria-sized
58.7
FSC-A
101
102
103
SS
C-
A
101 102 103
syto
78.4
SYTO9
0
200
400
600
101 102 103
IgA
0.26
SYTO9
PE
 (I
gA
)
101
102
103
101 102 103
bacterial-sized particles nuclear stain gate IgA quantification
B DC
caco2 HT29-MTX
0
20
40
60
80
%
 b
ac
te
ria
 a
dh
er
ed
RAG (no IgA)
BF IgA
**
***
W
T
∆
cc
f
∆
P
S
B
/C W
T
∆
cc
f
∆
P
S
B
/C
0
50
100
150
pe
rc
en
t v
iab
le
af
te
r s
oa
kin
g 
in 
Ig
A
WT IgA ∆ccf IgA
ns
A
0
2
4
6
8
%
 b
ac
te
ria
 a
dh
er
ed
ns
WT WT ∆PSB/C
- RAG
∆ccfbacteria:
IgA source: RAG RAG
25
80
245
(kDa)
B.
 fr
ag
ilis
B.
 th
et
a
B.
 vu
lga
tu
s
25
80
245
(kDa)
W
T
∆
cc
f
∆
P
S
B
/C
B. fragilis IgA germfree IgA
25
80
245
(kDa)
W
T
∆
cc
f
∆
P
S
B
/C
B. theta IgA
E F G
 13 
 
Fig. S5. B. fragilis colonization phenotypes in RAG1-/- and B cell depleted mice. (A) 
Abundance of foreign strains exchanged between pairs of wild-type B. fragilis mono-colonized 
mice, either C57BL/6 (B6) and Rag1-/-, in colony forming units (CFU) per gram of feces 
(geometric mean and 95% confidence interval plotted for all line graphs with Sidak repeated 
measure 2-way ANOVA on log-transformed data, n = 9). (B) Abundance of initial strains 
corresponding to A. (C) Anti-CD20 experimental timeline with germ-free Swiss Webster mice. 
(D) Gating strategy for quantification of B cells to confirm depletion by anti-CD20 antibody and 
(E) example plots. (F) Quantification of B cells as a proportion of cell populations in the 
peritoneum, mesenteric lymph nodes, and lymphocyte fraction of the colon lamina propria (LP) 
following injection of anti-CD20 or isotype control antibody (Sidak 2-way ANOVA, n = 4, 5). 
(G) IgA concentration in feces as assessed by ELISA 3 weeks after second injection of anti-
CD20 or isotype control antibody (unpaired t test, n = 7). (H) Abundance of initial strains for 
Fig. 4C (n = 10) (* p < 0.05, ** p < 0.01, *** p < 0.001). 
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Fig. S6. In vivo phenotypes for B. fragilis in BALB/C and BALB/c IgA-/- mice. (A) Percent of 
B. fragilis coated in IgM in mono-colonized BALB/c and BALB/c IgA-/- mice (unpaired t test, n 
= 4). (B) Abundance of initial strains corresponding to Fig 4D (geometric mean and 95% 
confidence interval plotted for all line graphs with Sidak repeated measure 2-way ANOVA on 
log-transformed data, n = 9). (C) Abundance of foreign strains in mice mono-colonized with B. 
fragilis and challenged by gavage with B. fragilis (n = 5). (D) Abundance of initial strains 
corresponding to C. (E) Abundance of foreign strains of B. fragilis in SPF mice colonized with 
B. fragilis and co-housed (n = 10). (F) Abundance of initial strains corresponding to E. (G) 
Quantification of colon lumen colonization corresponding to Fig 4E (unpaired t test, n = 9).  (* p 
< 0.05, ** p < 0.01, *** p < 0.001). 
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Fig. S7. Aggregation of B. fragilis in vivo is affected by IgA and ccf. (A) Transmission 
electron micrographs of colon lumen contents of Swiss Webster mice mono-colonized with B. 
fragilis or B. fragilis ∆ccf (4 representative images for each). (B) Transmission electron 
micrographs of feces of BALB/c and BALB/c IgA-/- mice mono-colonized with B. fragilis (3 
representative images for each). 
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Fig. S8. 16S microbiome profiling of ex-germ-free mice. (A) Principle coordinate analysis of 
weighted UniFrac distances of fecal microbiomes between BALB/c and BALB/c IgA-/- mice. (B) 
Relative abundance of bacterial families in colon and ileal lumen and mucus in ex-germ-free 
BALB/c and IgA-/- mice. Most abundant 12 families assigned colors; remaining families 
assigned random shades of gray. 
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Fig. S9. Analyses of exact sequence variants (ESVs) of interest in ex-germ-free mice. (A) 
Heatmap of relative abundance of ESVs assigned to Bacteroides or Parabacteroides in the 
mucus and lumen of the colon and ileum of BALB/c and BALB/c IgA-/- mice. (B) Relative 
abundance of highly IgA-bound taxa (LEfSe LDA effect size > 2) before and after sorting (ESVs 
in Figure 4I are the most abundant representatives of these taxonomic groups; “Candidatus 
Arthromitus” = SFB). 
A
B
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Table S1. 
Differentially expressed (adjusted p-value <0.05) genes in RNAseq of B. fragilis grown in 
culture with and without overexpression of ccfA. Genes are ordered by the fold-change. 
 
Locus ID Gene Log2(fold-change) (ccfA 
overexpression / vector) 
Adjusted P-value 
BF3583 ccfA 4.08 2.139E-106 
BF1021 wcfG (PSC) 2.93 1.29145E-15 
BF1009 upcY (PSC) 2.91 9.25035E-13 
BF1011 rmlA2 (PSC) 2.89 1.29145E-15 
BF1023 wcfI (PSC) 2.85 6.7139E-14 
BF1017 wcfD (PSC) 2.81 2.02687E-08 
BF1022 wcfH (PSC) 2.66 4.63823E-10 
BF1024 wcfJ (PSC) 2.44 1.07951E-07 
BF1019 wcfE (PSC) 2.44 5.99448E-07 
BF1012 rmlC1 (PSC) 2.42 4.56061E-06 
BF1015 wcfB (PSC) 2.42 1.98807E-07 
BF1025 wcfK (PSC) 2.42 1.65081E-07 
BF1010 upcZ (PSC) 2.21 1.33346E-05 
BF1020 wcfF (PSC) 2.19 0.000822972 
BF1377 wcfS (PSA) -2.07 0.005651271 
BF1376 wcfR (PSA) -2.15 0.001828779 
BF1369 wzx3 (PSA) -2.18 8.44926E-05 
BF1373 wcfO (PSA) -2.30 2.01292E-06 
BF1374 wcfP (PSA) -2.41 5.18014E-07 
BF1372 wzy3 (PSA) -2.44 9.8695E-08 
BF1370 wcfM (PSA) -2.45 7.08576E-08 
BF1371 wcfN (PSA) -2.45 3.10176E-08 
BF0466 Putative protein -2.48 1.65081E-07 
BF1375 wcfQ (PSA) -2.62 3.87573E-10 
BF1368 upaZ (PSA) -2.67 8.15223E-12 
BF1367 upaY (PSA) -2.75 6.50178E-13 
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Table S2. 
Differentially expressed (adjusted p-value < 0.05) genes in mice mono-colonized with B. fragilis 
or B. fragilis ∆ccf. Genes are ordered by the absolute value of the fold-change.   
 
Gene Log2(fold-change) 
(WT/∆ccf) 
Adjusted P-value 
Igkv4-61 -4.29 0.003125755 
Igkv8-19 4.18 1.51E-06 
Igkv3-12 -3.99 0.049083696 
Ighv1-70 3.74 2.28E-07 
Ighv1-5 -3.35 0.024434919 
Gpr63 -2.44 0.038541457 
Igkv6-23 2.03 3.13E-05 
Cyr61 -1.83 6.56E-07 
Ighv8-5 1.82 0.001789717 
Nr4a1 -1.74 2.69E-10 
Dusp1 -1.39 1.27E-07 
Fos -1.36 1.02E-06 
Egr1 -1.10 1.19E-06 
Sik1 -0.97 3.69E-05 
Klf2 -0.90 0.017155274 
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Table S3. 
DEseq analysis of exact sequence variants (ESVs) differing in abundance according to mouse 
genotype in either feces or the lumen and mucus of the ileum and colon of ex-germ-free mice. 
 
Enriched in: Sample type log2(fold-change) Adjusted p-value Best taxonomic assignment 
BALB/c mucus and lumen -8.634412444 0.000312846 Mollicutes RF39 
BALB/c mucus and lumen -3.905449189 0.000551256 Bacteroides fragilis 
BALB/c mucus and lumen -3.519511063 0.001725039 Lachnospiraceae 
IgA-/- mucus and lumen 2.821434619 0.001983777 Ruminoccus 
IgA-/- mucus and lumen 5.7119259 0.001221637 Clostridiales 
IgA-/- mucus and lumen 5.039308072 2.76E-05 Lachnospiraceae 
IgA-/- mucus and lumen 3.467202384 2.76E-05 Ruminoccus gnavus 
IgA-/- mucus and lumen 7.097420438 4.84E-08 Alphaproteobacteria BD7-3 
     
BALB/c feces -24.05671228 3.37E-23 Mollicutes RF39 
BALB/c feces -7.354148271 1.01E-06 Lachnospiraceae 
BALB/c feces -5.70390907 0.00543052 Coprococcus 
IgA-/- feces 4.450515436 0.008991039 Clostridiales 
IgA-/- feces 2.283274756 0.001376256 Adlercreutzia 
IgA-/- feces 8.12403428 2.37E-08 Alphaproteobacteria BD7-3 
IgA-/- feces 20.67955327 3.84E-20 Clostridiales 
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Table S4. 
Bacterial strains and plasmids used in this study.   
 
Strain / Plasmid Description Source 
Bacteroides fragilis 
NCTC9343 
Type strain, parent for all mutants in this study ATCC 
Bacteroides 
thetaiotaomicron 
ATCC 29148 
Type strain ATCC 
Bacteroides 
vulgatus ATCC8482 
Type strain ATCC 
B. fragilis ∆ccf An in-frame deletion within the operon containing ccfC, 
ccfD, and ccfE (BF3581-79) 
(26) 
B. fragilis ∆PSC An in-frame deletion of non-regulatory genes in the PSC 
locus (BF1011-26) 
This study 
B. fragilis ∆PSB An in-frame deletion of non-regulatory genes in the PSB 
locus (BF1895-1914) 
(67) 
B. fragilis ∆PSB/C ∆PSC mutation made in a ∆PSB background This study 
pFD340 Escherichia coli (Carbenicillin) / Bacteroides 
(Erythromycin) shuttle vector 
(68) 
pFD340-ccfA Overexpression of the sigma factor ccfA using the IS4351 
promoter on pFD340 
This study 
pFD340-chlor Marker plasmid for mouse colonization experiments 
(Erythromycin, Chloramphenicol) 
(26) 
pFD340-tet Marker plasmid for mouse colonization experiments 
(Erythromycin, Tetracycline) 
(26) 
pNJR6 Suicide plasmid for allelic exchange (Kanamycin for E. coli, 
Erythromycin for B. fragilis) 
(69) 
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Table S5. 
Primers used for cloning, generating mutants, and qPCR.   
 
Primer Sequence Purpose Source 
∆PSC 
primer-1 
GTGGATCCAAATGCGTTGCTTTTGCTTT Left flank PSC 
5’ 
This study 
∆PSC 
primer-2 
AAACCATGGTTCGAAATCGTTTTGCTTCA Left flank PSC 
3’ 
This study 
∆PSC 
primer-3 
GATTTCGAACCATGGTTTATGCTGGCTTT Right flank 
PSC 5’ 
This study 
∆PSC 
primer-4 
TTGGATCCAACACTACGCCTACCCGATG Right flank 
PSC 3’ 
This study 
PSC 
wildtype 1 
GGAGGATGTTTGAATTGGTGG PSC WT check 
5’ 
This study 
PSC 
wildtype 2 
CCCGCTTAATGCCCTAAAAT PSC WT check 
3’ 
This study 
PSC KO 1 GGAGGATGTTTGAATTGGTGG PSC KO check 
5’ 
This study 
PSC KO 2 TATCCTGATGTTCTGCTTTTCCG PSC KO check 
3’ 
This study 
ccfA 1 AAGGATCCTGCGCAACTGATATTGTTAGAA ccfA (BF3583) 
cloning 5’ 
This study 
ccfA 2 AAGAGCTCCGAAATCTACTCAGTGTAAATGGA ccfA (BF3583) 
cloning 3’ 
This study 
q. gyrB 1 GTGAATGAGGACGGCAGTTT qPCR gyrase This study 
q. gyrB 2 CTCGATGGGGATGTTTTGTT qPCR gyrase This study 
q. PSA 1 TTGTATCCGCAAGGGAGAGA qPCR PSA This study 
q. PSA 2 CGCTCCATACTGCCCATATT qPCR PSA This study 
q. PSB 1 GCTTTTGGCTTAATGCTTGTTGG qPCR PSB This study 
q. PSB 2 GCCTAGAAGTACAATTAGCCCGA qPCR PSB This study 
q. PSC 1 TGTTTGGTGGCTGCTACTTG qPCR PSC This study 
q. PSC 2 AGGTGAAGTTTGAAGCCAAGG qPCR PSC This study 
q. PSD 1 CAATTTGGGAGGTGCGTTGT qPCR PSD This study 
q. PSD 2 ACGACCAATCCAAAACCCCA qPCR PSD This study 
q. PSE 1 TGCCTCCCTGTTGGTGAAAA qPCR PSE This study 
q. PSE 2 AGCGTTAGCCAAACTCCGTA qPCR PSE This study 
q. PSF 1 TTCTATCGTTCAGCGTGCGA qPCR PSF This study 
q. PSF 2 TGCCCATACGCCAAATCCTT qPCR PSF This study 
q. PSG 1 CAAGTACACCTGTCAGTAGTTTGC qPCR PSG This study 
q. PSG 2 GCAACTTCCAATTCCTAACAAAAGA qPCR PSG This study 
q. PSH 1 GGAAAACAGTCGGAATGGCTC qPCR PSH This study 
q. PSH 2 TTCCACACACGCAGACACAA qPCR PSH This study 
q. ccfA 1 GGAATTTGCATGACACTTAT qPCR ccfA (26) 
q. ccfA 2 CTGAGAGGTTTCATCTTCTG qPCR ccfA (26) 
q. ccfB 1 AGTGTCCCCACTTCATCGTC qPCR ccfB (26) 
q. ccfB 2 TGAAACTTTTGCCGGAGAAT qPCR ccfB (26) 
q. ccfC 1 GATGAACTGATAGCCCATTA qPCR ccfC (26) 
q. ccfC 2 TAGCGATGACTAAAGGTGTT qPCR ccfC (26) 
q. ccfD 1 CGGTTATATGCTTTTCAAAC qPCR ccfD (26) 
q. ccfD 2 CAAATAGAAATCTGCCAAAC qPCR ccfD (26) 
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